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ttp://dx.doi.org/10.1016/j.ajpath.2014.02.009Peripheral neuropathy is the most frequent neurological complication of HIV infection, affecting
more than one-third of infected patients, including patients treated with antiretroviral therapy.
Although emerging noninvasive techniques for corneal nerve assessments are increasingly being used
to diagnose and monitor peripheral neuropathies, corneal nerve alterations have not been charac-
terized in HIV. Here, to determine whether SIV infection leads to corneal nerve ﬁber loss, we
immunostained corneas for the nerve ﬁber marker bIII tubulin. We developed and applied both
manual and automated methods to measure nerves in the corneal subbasal plexus. These counting
methods independently indicated signiﬁcantly lower subbasal corneal nerve ﬁber density among SIV-
infected animals that rapidly progressed to AIDS compared with slow progressors. Concomitant with
decreased corneal nerve ﬁber density, rapid progressors had increased levels of SIV RNA and CD68-
positive macrophages and expression of glial ﬁbrillary acidic protein by glial satellite cells in the
trigeminal ganglia, the location of the neuronal cell bodies of corneal sensory nerve ﬁbers. In
addition, corneal nerve ﬁber density was directly correlated with epidermal nerve ﬁber length. These
ﬁndings indicate that corneal nerve assessment has great potential to diagnose and monitor HIV-
induced peripheral neuropathy and to set the stage for introducing noninvasive techniques to
measure corneal nerve ﬁber density in HIV clinical settings. (Am J Pathol 2014, 184: 1652e1659;
http://dx.doi.org/10.1016/j.ajpath.2014.02.009)Supported by NIH grants NS055651, MH070306, NS077869, T32
OD011089, and P40 OD013117 (J.L.M.).
Disclosures: None declared.Peripheral neuropathy (PN) is the most frequent neurolog-
ical complication caused by HIV-1, affecting more than
one-third of infected persons, including patients receiving
combination antiretroviral therapy.1,2 The typical clinical
presentation is known as distal sensory polyneuropathy, a
length-dependent neuropathy that is characterized by bilat-
eral aching, painful numbness or burning, and is most
pronounced in the lower extremities.3,4 Although HIV-
induced PN (HIV-PN) is not life threatening, this debili-
tating disorder greatly compromises patient quality of life.1
Currently, skin biopsy is the accepted standard forstigative Pathology.
.measuring the loss of small, unmyelinated C ﬁbers in the
epidermis, one of the earliest detectable signs of damage to
the peripheral nervous system (PNS).5e7 However, skin
biopsy is an invasive procedure, and longitudinal assess-
ment requires repeated surgical biopsies. Electrophysiolog-
ical testing to measure properties of peripheral nerve
conduction is not considered a viable alternative because
Corneal Nerve Fiber Loss in SIVcurrent methods lack the sensitivity required to detect
damage to small, unmyelinated ﬁbers, especially in early
stages of disease.8,9 For these reasons, new, sensitive,
noninvasive methods of assessing small ﬁber nerve damage
are urgently needed to detect and monitor PN in persons
infected with HIV.
Like HIV, small sensory nerve ﬁber loss is common in
patients with diabetes mellitus and results in a clinical
syndrome that closely resembles HIV distal sensory poly-
neuropathy.10 Of interest, studies have documented the
utility of measuring changes in corneal sensory innervation
to track diabetic neuropathy as an alternative to measuring
epidermal nerve ﬁber (ENF) density via skin biopsy. In
particular, decreases in the nerve density in the corneal
subbasal plexus (SBP) have been reported in both isolated
corneal whole mount studies and by noninvasive in vivo
corneal confocal microscopy (CCM).11e15
Although corneal nerve assessments have found
increasing value as a surrogate to evaluate ENFs in diabetic
PN, the use of corneal alterations in tracking HIV-induced
neuropathy has yet to be explored. To study the pathogenesis
of HIV-induced PNS disease, our group developed a SIV-
infected macaque model that closely recapitulates key PNS
alterations seen in patients with HIV with PN. These changes
include macrophage inﬁltration, SIV replication, and
neuronal loss in sensory ganglia, including the trigeminal
ganglia, which house the cell bodies of sensory neurons that
innervate the cornea.16,17 In this report, we aimed to deter-
mine whether SIV infection leads to decreases in corneal
nerve ﬁber (CNF) density, whether changes in corneal nerves
correspond with the extent of SIV replication and the severity
of cellular immune responses in the trigeminal ganglia, and
whether CNF density correlates with ENF length, thereby
setting the stage for follow-up CCM investigation. To ach-
ieve optimal immunostaining of the corneal SBP, we modi-
ﬁed an immunohistochemical staining method developed by
Marfurt et al.18 Because conventional image analysis of the
corneal nerve is labor intensive and requires trained
observers, we developed two novel counting methods: a
relatively simple manual counting method of nerve ﬁbers and
an automated method of nerve detection and counting to
facilitate efﬁcient, objective assessment of nerve ﬁber density.
Materials and Methods
Animals
Male juvenile pigtailed macaques (Macaca nemestrina)
were inoculated intravenously with either a combination of
the infectious clone SIV/17E-Fr and the viral swarm SIV/
DeltaB670 (nZ 7) or with the infectious clone SIV/17E-Fr
(n Z 4).19 Serology was negative for SIV, simian T-cell
leukemia virus, and simian type D retrovirus for all macaques
before inoculation. For control purposes, corneas also were
obtained from three additional uninfected macaques. Ani-
mals were housed in Johns Hopkins University facilities thatThe American Journal of Pathology - ajp.amjpathol.orgare fully accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care International.
Macaques were fed a commercial macaque diet (Harlan,
Indianapolis, IN), given water ad libitum, and provided with
environmental enrichment daily. All procedures were
approved by the Johns Hopkins University Institutional
Animal Care and Use Committee and were conducted in
accordance with guidelines set forth in the Animal Welfare
Regulations (US Department of Agriculture) and the Guide
for the Care and Use of Laboratory Animals (Ofﬁce of
Laboratory Animal Welfare).
Viral Load
To evaluate SIV RNA levels, RNA was extracted from
frozen trigeminal ganglia or plasma. Viral load was
measured by quantitative RT-PCR with the use of primers to
quantitate SIV gag.20
Cornea IHC
After euthanasia, an 8-mm biopsy punch was used to
remove the central cornea from the eye. Corneas were
immediately placed in 0.1 mol/L PBS and stored at 4C
for 8 hours before preservation in 10% neutral-buffered
formalin. Corneas were then ﬁxed overnight at 4C, rinsed
three times in PBS, and cryoprotected overnight at 4C in
20% glycerol/0.1 mol/L Sørensen’s phosphate buffer.
Before immunostaining, a 5-mm biopsy punch was used to
remove the central corneal button, which was then immu-
nostained as a free-ﬂoating whole mount. To enhance
permeability, whole mounts were incubated for 48 hours at
37C in 0.01% hyaluronidase (type IV-S; Sigma-Aldrich,
St. Louis, MO) and 0.1% EDTA (Sigma-Aldrich) in 0.1
mol/L PBS (pH 5.3). Corneal buttons were then washed
three times for 15 minutes each in PBS that contained 0.3%
Triton X-100 and also between each subsequent immuno-
staining step. Nonspeciﬁc labeling was blocked by incuba-
tion at room temperature for 2 hours in blocking serum (1%
bovine serum albumin in PBS that contained 0.3% Triton
X-100) before a 4-day incubation at room temperature with a
mouse monoclonal antibody against the neuronal marker bIII
tubulin (1:500; Promega Corporation,Madison,WI). Corneal
buttons were then incubated in secondary antibody (bio-
tinylated goat anti-mouse IgG, 1:200; Vector Laboratories,
Burlingame, CA) followed by avidin-biotin-horseradish
peroxidase complex (Vectastain Elite ABC Reagent; Vector
Laboratories) for 2 hours each at room temperature and sub-
sequent detection with the diaminobenzidine chromogen
(Sigma-Aldrich) after incubation for 10 to 15 minutes. After
washing, corneas were mounted on chrome alum-gelatine
coated slides and air-dried overnight. Tissue slides were then
washed in distilled water, dehydrated in graded alcohols,
cleared in HistoClear (National Diagnostics, Atlanta, GA),
and coverslipped with Permount (Fisher Scientiﬁc, Pitts-
burgh, PA).1653
Dorsey et alQuantitative Assessment of SBP: Image Acquisition
For each cornea, images of ﬁve 200 ﬁelds (one ﬁeld from
each quadrant and one ﬁeld from the central cornea) of the
SBP were captured with a Retiga 2000R digital camera
(QImaging, Surrey, BC, Canada) mounted on a Nikon E600
microscope (Nikon, Tokyo, Japan). Several serial Z-stack
images were taken of each ﬁeld to accommodate for the
curvature of the cornea, thus bringing the entire SBP of the
ﬁeld into a single focused plane. The subregions of SBP in
focus for each image were selected in Adobe Photoshop
CS4 software version 11.0 (Adobe Systems, San Jose, CA)
and autoblended to assemble a single cohesive image of the
subbasal nerve plexus for each ﬁeld. The blended images
were subsequently used in the quantitative assessment of
nerve ﬁber density.
Manual Assessment
Corneal SBP nerves were counted with Stereo Investigator
software version 9 (MicroBrightField Inc, Colchester, VT)
to draw three transect lines across each image oriented
perpendicular to the longitudinal subbasal nerve ﬁbers. The
number of nerves crossing each transect was counted and
then divided by the total transect length. For each image, the
number of nerves crossing each of the three transects was
averaged, and the ﬁnal mean number of corneal nerves per
millimeter was derived from the ﬁve images for each animal.
Automated Assessment
To automate nerve counts in the cornea, a custom algorithm
was developed speciﬁcally to quantify nerve ﬁbers in SBP
images to emulate the manual counting method. First,
anisotropic diffusion ﬁltering was applied to reduce noise
while preserving the structure of each image.21 The linear
structure of the nerves was then enhanced across various
scales with the use of Frangi’s Hessian-based ﬁlter.22 To
exploit the piecewise linearity of the nerves, the image was
subdivided into smaller regions in which nerves exhibited
the same orientation. Next, the subimages were reoriented to
ﬁnd the best (ie, most prominent) orientation of the nerves,
deﬁned as minimal entropy of the distribution of image data
in the resulting 1D proﬁle. The number of visible nerves
was determined by summing image data along the most
prominent orientation and then counting the peaks in the 1D
proﬁle, with each peak representing a single nerve ﬁber. The
nerve count was derived cumulatively from the sum of the
peaks per image for each of the ﬁve images.
Trigeminal Ganglia IHC
IHC was performed on HistoChoice-ﬁxed (HistoChoice
Tissue Fixative; Amresco, Solon, OH) parafﬁn-embedded
sections of trigeminal ganglia. Tissue sections were depar-
afﬁnized by heating for 30 minutes at 60C, cleared in1654changes of HistoClear (National Diagnostics), and then
rehydrated in a graded series of alcohol. Slides were pre-
treated for antigen retrieval by heating with 0.01 mol/L
sodium citrate (pH 6.0) before immunostaining. Endoge-
nous peroxidases were blocked with 3% hydrogen peroxide
in methanol, then nonspeciﬁc labeling was blocked with
dilute block (Vector Laboratories). Sections were incubated
in the appropriate primary antibody dilution [CD68, 1:4000,
clone KP1, and glial ﬁbrillary acidic protein (GFAP),
1:80,000; Dako, Carpinteria, CA] for 1 hour, followed by
biotinylated anti-mouse/rabbit secondary antibody and avidin-
biotin-horseradish peroxidase complex (Vectastain Elite ABC
Reagent; Vector Laboratories) for 30 minutes each with sub-
sequent detection with the diaminobenzidine chromogen
(Vector Laboratories). Tissue sections were then washed,
cleared, and coverslipped with Permount (Fisher Scientiﬁc).
The amount of immunostaining for the macrophage marker
CD68 and satellite cell marker GFAP was measured by digi-
tized image analysis as described.17 For each trigeminal gan-
glion, 20 nonoverlapping ﬁelds at 200 magniﬁcation were
captured with a Retiga 2000R digital camera (QImaging)
mounted on a Nikon E600 microscope (Nikon). Binarized
images were then analyzed with iVision imaging software
version 4.0.14 (BioVision Technologies, Exton, PA). The
mean total area occupied by the immunopositive pixels in the
trigeminal ganglion was calculated for each animal.
ENF IHC
To measure ENF density in the skin of the plantar footpad
surface of the hind limb, 3-mm diameter punch footpad
samples were obtained at necropsy from the identical site.
Footpad skin sections were ﬁxed for 12 to 24 hours in 2%
paraformaldehyde/lysine/periodate ﬁxative at 4C, rinsed
with 0.08 mol/L Sørensen’s phosphate buffer, and then
transferred to cryoprotective buffer (20% glycerol in 0.08
mol/L Sørensen’s phosphate buffer) until processed as pre-
viously described.23 Cryoprotected samples were sectioned
at a thickness of 50 mm on a sliding microtome and then
immunostained for PGP9.5, a pan axonal marker (1:2000;
Chemicon, Temecula, CA), as previously described.24,25
Measurement of ENF Length
PGP9.5 ENF length was quantiﬁed with unbiased stereol-
ogy methodology by using the space ball probe on Stereo
Investigator software version 9 (MBF Bioscience, Williston,
VT) described by Ebenezer et al26,27 and Mouton.28 Three
50-mm PGP9.5 immunostained sections from one plantar
footpad biopsy from each animal were measured. The area
of interest was deﬁned as the epidermal region that extended
from the epidermal/dermal junction to the stratum corneum
and was drawn under a Nikon 4/0.2 Plan Apo objective on
a Nikon Eclipse E600 light microscope. The ENF length
was measured with a Nikon 60/1.40 oil Plan Apo objec-
tive. The radius of the hemisphere probe was 30 mm with aajp.amjpathol.org - The American Journal of Pathology
Figure 1 SIV PVL over time and SIV-induced alterations in SIV RNA,
CD68, and GFAP expressions in trigeminal ganglia according to severity of
SIV infection. A: Longitudinal plasma SIV RNA levels depict a markedly
lower viral set point among the singly inoculated macaques, classiﬁed as
SPs, than do the dual-inoculated macaques that sustained high plasma
viremia and progressed to AIDS, classiﬁed as RPs. B: A scatter plot
depicting the SIV viral load in the TG indicates increased SIV replication in
the TG of RPs compared with SPs. C: CD68 immunostaining of the TG in-
dicates a marked increase in macrophage activation and inﬁltration in the
TG among the RPs, concomitant with the increased severity of SIV infec-
tion. D: GFAP immunostaining of glial satellite cells in the TG was similarly
signiﬁcantly increased among the RPs. Horizontal lines represent median
values. P Z 0.024 (B) and P Z 0.0095 (D), both by Mann-Whitney test.
ROI, region of interest; RP, rapid progressor; SP, slow progressor; TG, tri-
geminal ganglion.
Corneal Nerve Fiber Loss in SIVguard zone of 2 mm. Only nerve ﬁbers within the epidermis
were counted. The results were expressed as the length of
PGP9.5 nerve ﬁbers. All stereology measurements were
obtained with DAT ﬁles of Stereo Investigator.27Figure 2 Representative bIII tubulin immunostaining of corneal SBP
nerve ﬁbers in rapid progressors compared with slow progressors. A: Image of
the corneal SBP of 5 mm corneal whole mount immunostained for the
neuronalmarkerbIII tubulin shows the dense sensory nerveﬁbers throughout
the cornea. B and C: Representative images of the SBP among slow pro-
gressors show dense, regularly spaced nerve ﬁbers. D and E: In contrast,
images of the SBP from the rapid progressors exhibit lower CNF density than
the slow progressors. For image comparison, black and white images were
pseudocolored to green and black with the use of iVision software. Scale
barZ 100 mmol/L. Original magniﬁcations: 20 (A); 200 (BeE).Results
SIV Disease Progression: Deﬁning Rapid- versus Slow-
Progressing SIV Groups
Seven animals were dual-inoculated with SIV/17E-Fr, an
infectious clone, and with SIV/DeltaB670, an immunosup-
pressive swarm. An additional four animals were inoculated
with only the molecular clone SIV/17E-Fr. To track SIV
disease progression, plasma viral loads (PVLs) were
measured by quantitative RT-PCR in longitudinal samples
obtained from acute through terminal disease time points.
During acute infection, all animals developed similar high
PVLs with peak SIV RNA levels at 10 to 14 days after
inoculation of 107 to 109 RNA copies/mL (Figure 1A).
Among the dual-inoculated animals, the viral set point
remained high, and at the time of sacriﬁce (84 days after
inoculation), dual-inoculated animals had progressed toThe American Journal of Pathology - ajp.amjpathol.orgAIDS with severely diminished CD4þ T-lymphocyte counts
(median terminal PVL Z 1.18  107 copies/mL, median
terminal CD4þ T cells/mL Z 276). In contrast, the singly
inoculated animals had a much lower PVL set point after
acute infection that continued to the time of sacriﬁce (median
terminal PVLZ 1.89 103 copies/mL) and also maintained
a signiﬁcantly higher CD4þ T-lymphocyte count (median
terminal CD4þ T cells/mLZ 989; PZ 0.0061) than did the
dual-inoculated macaques. Given these differences between
groups, dual-inoculated versus singly inoculated animals
were classiﬁed as rapid progressors and slow progressors,
respectively, in subsequent group comparisons.1655
Dorsey et alCNF Density
To determine whether SIV infection induced nerve ﬁber loss
in the corneal SBP, cornea whole mounts 5 mm in diameter
were immunostained for the neuronal marker bIII tubulin
(Figure 2A). Visual inspection of these images indicated lower
nerve ﬁber density in the rapid progressor group than in the
slow progressor group (Figure 2, BeE). To measure the
number of CNFs, identical 200 images of the SBP were
analyzed both by counting manually and by an automated
counting method (Figure 3, AeD). Manual and automated
CNF counts showed a strong, positive correlation between
nerve ﬁber counts (PZ 0.0004, rZ 0.90), indicating excellent
agreement between the two counting methods (Figure 3E).
Both counting methods showed a signiﬁcantly decreased
CNF count among the rapid progressors than among the slowFigure 3 Manual and automated methods to measure CNF counts in RP comp
represents the bIII tubulin immunostained images acquired for both the manual
assessment, transects (blue lines) were drawn perpendicular to the longitudinal n
were counted. The number of nerve ﬁbers counted was then divided by the leng
calculated. C: The automated method used a custom algorithm (Voxeleron) to iden
depicted which nerve ﬁbers would be detected by the algorithm. D: The automated
ﬁrst subdivided into 16 smaller images that were then rotated to achieve a vertical
vertical axis (middle panel), generating a 1D proﬁle in which each peak represen
ﬁbers (bottom panel). Lower peaks that did not correspond to a nerve ﬁber were e
the two counting methods. F: A statistically signiﬁcant decrease in CNFs among the
quantitative assessment. G: Similarly, the manual method of quantitative assessm
Lines represent median values (EeG). PZ 0.0061 and PZ 0.024 (G), both by Ma
Original magniﬁcation 200 (AeC). RP, rapid progressors; SP, slow progressors.
1656progressors; the decline was more robust by using the auto-
mated detection algorithm (P Z 0.024 for manual counts;
PZ 0.0061 for automated counts) (Figure 3, F and G). CNF
loss was uniform across sample ﬁelds in individual animals.
Neither manual nor automated CNF counts from uninfected
control animals were signiﬁcantly different from corneal nerve
counts measured in slow progressors (P > 0.05). This was an
expected ﬁnding, given that approximately 50% of persons
infected with HIV do not have evidence of PNS damage.
Trigeminal Ganglia SIV Replication Levels
Previous studies have shown SIV replication in the sensory
ganglia of dual-inoculated SIV-infected macaques at termi-
nal end points.16,17 To investigate whether SIV replication in
the trigeminal ganglia differed between progressor groups,ared with SP SIV-infected macaques. A: Image of the SBP of an RP animal
and automated quantitative assessment of CNF. B: For manual quantitative
erve trunks and nerve ﬁbers crossing each transect (denoted by red circles)
th of each transect, and the average number of nerves per millimeter was
tify and then quantify CNFs. Applying ﬁlters generated an output image that
algorithm used a series of steps to count nerve ﬁbers. Each200 image was
orientation (top panel). The image pixel data were then summed along the
ted a single nerve ﬁber denoted by an asterisk at the top of counted nerve
xcluded by thresholding. E: A strong positive correlation was found between
RP group versus the SP group was found by using the automated method of
ent also found a statistically signiﬁcant decrease in CNFs among the RPs.
nn-Whitney test; and PZ 0.0004, rZ 0.90, Spearman rank correlation (G).
ajp.amjpathol.org - The American Journal of Pathology
Figure 4 Relationship between ENF length and CNF counts obtained by
using either manual or automated corneal counting methods. A: A signif-
icant, direct correlation is observed between ENF length and CNF density by
using the manual method of quantitative assessment. B: The automated
method of CNF quantitative assessment also shows a signiﬁcant, direct
correlation between CNF and ENF length, indicating the potential of CNF
assessment as a surrogate measure in the evaluation of HIV-PN. Lines
represent median values. P Z 0.048, r Z 0.62 (A) and P Z 0.040,
r Z 0.64 (B), both Spearman rank correlation.
Corneal Nerve Fiber Loss in SIVSIV RNA levels were measured by quantitative RT-PCR.
SIV RNA in the trigeminal ganglia among the rapid pro-
gressors was signiﬁcantly elevated (median SIV
RNA Z 1076 copies/mg RNA; P Z 0.024) (Figure 1B)
compared with the slow progressors with low to undetectable
SIV RNA levels (median SIV RNAZ 3 copies/mg RNA).
Cellular Immune Responses in Trigeminal Ganglia
In the sensory ganglia of macaques, key cellular immune re-
sponders, including macrophages and satellite cells, are acti-
vated in response to SIV infection.16,17 To determine whether
there were differences in cellular immune responses between
the rapid progressor and slow progressor groups, trigeminal
ganglia sections were stained separately for the macrophage
marker CD68 and the satellite cell marker GFAP. The amount
of CD68 and GFAP immunostaining was then measured by
quantitative image analysis.29 Immunostaining for bothCD68-
positive macrophages and GFAP-expressing satellite cells was
higher in the rapid progressor group than in the slow pro-
gressor group (P Z 0.054 and P Z 0.0095, respectively)
(Figure 1, C and D). Furthermore, both macrophage (CD68
immunostaining: P Z 0.014, r Z 0.80) and satellite cell
activation (GFAP immunostaining: P Z 0.0031, r Z 0.88)
were strongly correlated with SIV RNA levels in the trigem-
inal ganglia, thus indicating a positive relationship between the
extent of productive SIV infection and corresponding severity
of inﬂammation in the sensory ganglia.
The CNF count measured by the automated algorithm
was inversely correlated with terminal PVL (P Z 0.040,
rZ 0.64), indicating a relationship between the extent of
productive SIV infection and corneal nerve damage. CNF
density was also related to both the extent of SIV replication
(P Z 0.067, r Z 0.65) and macrophage activation in the
trigeminal ganglia (P Z 0.067, r Z 0.61), but the small
group sizes in the study did not allow us to uncover deﬁn-
itive relationships. In contrast, satellite cell activation in the
trigeminal ganglia was not associated with CNF count
(P Z 0.10, r Z 0.55).
CNF Density versus ENF Measurements
To compare both manual and automated CNF counts with
ENF densities, we measured ENF densities in plantar foot
punches obtained from SIV-inoculated macaques immuno-
stained for the nerve ﬁber marker PGP9.5. We previously
have demonstrated that SIV induces loss of ENF in ma-
caques.17 Both manual and automated CNF counts were
strongly correlated with ENF measurements (P Z 0.048,
r Z 0.62 for manual counts; P Z 0.040, r Z 0.064 for
automated counts) (Figure 4, A and B).
Discussion
Because the cornea is the most densely innervated tissue in
the body, corneal nerve assessment is extremely sensitiveThe American Journal of Pathology - ajp.amjpathol.orgfor detecting damage to small sensory nerve ﬁbers
compared with other tests, including measurement of
intraepidermal nerve ﬁbers in the skin.11,30 The potential for
early detection of nerve damage, taken with the rapidity
and noninvasiveness of in vivo CCM, has led to increased
use of corneal nerve assessments to monitor and evaluate
a variety of peripheral neuropathies, particularly diabetic
PN.12,14,31e33 Despite the high prevalence of HIV-PN, as
well as the clinical similarities between HIV-PN and dia-
betic PN, alterations in corneal nerves among persons
infected with HIV have not yet been explored. With the use
of an SIV/macaque model that closely resembles HIV
infection, this study indicated loss of CNFs in the corneal
subbasal nerve plexus. Furthermore, CNF counts corre-
sponded closely with measurements of ENF length. CNF
loss also was associated with viral replication and cellular
immune activation in the trigeminal ganglia, the location of
the neuronal cell bodies of the corneal sensory nerve ﬁbers.
The relationship between inﬂammation and SIV replication
in the trigeminal ganglia and CNF loss imply that damage to
neurons in the trigeminal ganglia impairs the ability of
neurons to maintain sensory nerve ﬁber integrity. Together,
these ﬁndings indicate that emerging noninvasive tech-
niques to measure CNF alterations such as in vivo CCM
may be useful clinical tools to screen for and monitor pro-
gression of PN in patients infected with HIV.
Common critiques of current corneal nerve assessments
include the requirement for time-intensive manual image
analysis and confounding interobserver variability in the
recognition of nerve ﬁbers, underscoring the need for
trained observers.34,35 To overcome these difﬁculties, we
developed a consistent cornea immunostaining and image
acquisition protocol. To measure CNFs in the SBP, we then
developed and validated two rapid, easily applied methods
for nerve measurements in the SBP: a manual method that
counts all nerve ﬁbers crossing a given transect and an
automated method that uses a custom algorithm to identify1657
Dorsey et aland count nerve ﬁbers. Although both methods offer viable
methods of assessment, the beneﬁt of an automated method
includes elimination of interobserver variability, thereby
eliminating counting bias and subjectivity.
Both counting methods showed decreased CNF density in
the rapid progressor group; the difference between the rapid
and slow progressor groups was most pronounced with the
use of the automated method of nerve detection. This
discrepancy may reﬂect our method of immunostaining that
enhances visibility of all CNFs as well as the differences in
the sensitivity of nerve ﬁber detection between the methods.
With the use of the manual method, every nerve ﬁber is
counted regardless of size or thickness to reduce counting
subjectivity. In contrast, the automated algorithm is less likely
to identify very ﬁne nerve branches, with detection largely
limited to the thicker nerve trunks, similar to current in vivo
CCM technology wherein many of the very ﬁne nerve ﬁbers
also elude detection.15,36 The difference in nerve ﬁber pop-
ulations identiﬁed suggests that the density of thicker nerve
trunks may better reﬂect the severity of CNF damage in SIV.
In this study, to reduce analysis time and to minimize
observer variability, we focused on CNF density measure-
ments, a parameter shown to have high intraobserver and
interobserver repeatability and agreement.37 However, other
morphological parameters such as ﬁber length, branch den-
sity, and tortuosity of subbasal corneal nerves also have been
shown to undergo signiﬁcant changes throughout progres-
sion of PN disease, even when clinical symptoms are mild or
absent and skin ENFmeasurements appear normal.12e15,30,38
Future studies that use corneal nerve assessment as a surro-
gate for HIV-PN should also include measurements of these
parameters to expand our understanding of CNF damage as
well as repair throughout the course of infection. Moreover,
in this study we were limited to terminal end points of disease
because of the immunohistochemical staining method of
nerve visualization that necessitated dissected corneal whole
mounts. However, the move to noninvasive and thus
repeatable methods of nerve detection such as in vivo CCM
would enhance study of PN by enabling early detection of
damage and progression of nerve ﬁber deterioration and
would enable assessment of therapeutic strategies in the SIV/
macaque model. Furthermore, adapting in vivo CCM for use
in tracking HIV-induced PNS damage in patients may be of
great value in identifying and preventing early PNS damage
independent of performing skin biopsies.Acknowledgments
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